menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Expert Perspectives on Treating Relapsed or Refractory Multiple Myeloma

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    The future may be looking bright for patients with multiple myeloma as more therapies emerge. So how can clinicians help to improve patient care? Join Dr. Charles Turck as he dives into this topic with Dr. Morie Gertz, Hematology Specialist at the Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, and Dr. Ravi Vij, Professor of Medicine in the Oncology Division and Section of Bone Marrow Transplantation at the Washington University School of Medicine in St. Louis, Missouri.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    The future may be looking bright for patients with multiple myeloma as more therapies emerge. So how can clinicians help to improve patient care? Join Dr. Charles Turck as he dives into this topic with Dr. Morie Gertz, Hematology Specialist at the Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, and Dr. Ravi Vij, Professor of Medicine in the Oncology Division and Section of Bone Marrow Transplantation at the Washington University School of Medicine in St. Louis, Missouri.

Facebook Comments

Schedule23 Feb 2024